| SMS Pharmaceuticals Ltd Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 |
| 15/03/2023 | bse |
| SMS Pharmaceuticals Ltd Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 |
| 15/03/2023 | bse |
| SMS Pharmaceuticals Ltd Announcement under Regulation 30 (LODR)-Earnings Call Transcript |
| 14/02/2023 | bse |
| SMS Pharmaceuticals Ltd Announcement under Regulation 30 (LODR)-Newspaper Publication |
| 10/02/2023 | bse |
| SMS Pharmaceuticals Ltd Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome |
| 10/02/2023 | bse |
| SMS Pharmaceuticals Ltd Announcement under Regulation 30 (LODR)-Press Release / Media Release |
| 09/02/2023 | bse |
| SMS Pharmaceuticals Ltd Announcement under Regulation 30 (LODR)-Investor Presentation |
| 09/02/2023 | bse |
| SMS Pharmaceuticals Ltd Financial Results For The Quarter Ended 31St December 2022 |
| 09/02/2023 | bse |
| SMS Pharmaceuticals Ltd Board Meeting Outcome for Outcome Of Board Meeting And Financial Results |
| 09/02/2023 | bse |
| SMS Pharmaceuticals Ltd Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
| 08/02/2023 | bse |
